Skip to main content
. Author manuscript; available in PMC: 2021 Feb 4.
Published in final edited form as: Heroin Addict Relat Clin Probl. 2021;23(2):5–12.

Table 3.

Treatment outcome variables for naltrexone-treated patients

Time in telemedicine treatment
Baseline 1 week 1 month 3 months
Percent (n) engaged 100% 92% (23) 80% (20) 48% (12)
% noncumulative negative urine opioid screens of engaged patients 71% (17/24) 90% (18/20) 82% (14/17) 100% (9/9)

Patient engagement reported on total n of 25.